Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - memantine hydrochloride, quantity: 10 mg - tablet, film coated - excipient ingredients: magnesium stearate; purified talc; croscarmellose sodium; colloidal anhydrous silica; microcrystalline cellulose; titanium dioxide; hypromellose; macrogol 400 - treatment of the symptoms of moderately severe to severe alzheimer's disease

Malta - English - Medicines Authority

teva pharma b.v. swensweg 5, 2031 ga haarlem, netherlands - memantine hydrochloride - film-coated tablet - memantine hydrochloride 10 mg - psychoanaleptics

Malta - English - Medicines Authority

teva pharma b.v. swensweg 5, 2031 ga haarlem, netherlands - memantine hydrochloride - film-coated tablet - memantine hydrochloride 20 mg - psychoanaleptics

Malta - English - Medicines Authority

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - memantine hydrochloride - film-coated tablet - memantine hydrochloride 10 mg - psychoanaleptics

Malta - English - Medicines Authority

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - memantine hydrochloride - film-coated tablet - memantine hydrochloride 20 mg - psychoanaleptics

Malta - English - Medicines Authority

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - memantine hydrochloride - film-coated tablet - memantine hydrochloride 10 mg - psychoanaleptics

Malta - English - Medicines Authority

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - memantine hydrochloride - film-coated tablet - memantine hydrochloride 20 mg - psychoanaleptics

Malta - English - Medicines Authority

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - memantine hydrochloride - oral solution - memantine hydrochloride 10 mg - psychoanaleptics

United States - English - NLM (National Library of Medicine)

aphena pharma solutions - tennessee, llc - memantine hydrochloride (unii: jy0wd0ua60) (memantine - unii:w8o17sjf3t) - memantine hydrochloride is indicated for the treatment of moderate to severe dementia of the alzheimer's type. memantine hydrochloride is contraindicated in patients with known hypersensitivity to memantine hydrochloride or to any excipients used in the formulation. pregnancy category b there are no adequate and well-controlled studies of memantine in pregnant women. memantine hcl should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. memantine given orally to pregnant rats and pregnant rabbits during the period of organogenesis was not teratogenic up to the highest doses tested (18 mg/kg/day in rats and 30 mg/kg/day in rabbits, which are 9 and 30 times, respectively, the maximum recommended human dose [mrhd] on a mg/m2 basis). slight maternal toxicity, decreased pup weights and an increased incidence of non-ossified cervical vertebrae were seen at an oral dose of 18 mg/kg/day in a study in which rats were given oral memantine beginning pre-mating and continu

Malta - English - Medicines Authority

clonmel healthcare limited waterford road, clonmel, co. tipperary e91 d768, ireland - memantine hydrochloride - oral solution - memantine hydrochloride 10 mg/ml - psychoanaleptics